|Mr. Robert J. Palmisano||Chief Exec. Officer, Pres and Exec. Director||2.57M||N/A||72|
|Mr. Lance A. Berry||Chief Financial Officer and Sr. VP||845.2k||N/A||45|
|Mr. Robert P. Burrows III||Sr. VP of Supply Chain||930.01k||N/A||70|
|Mr. Peter S. Cooke||Pres of International||949.73k||N/A||52|
|Mr. Kevin D. Cordell||Pres of US||823.08k||N/A||51|
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. Wright Medical Group N.V. markets and sells its products through direct sales representatives and independent sales agencies in the United States; and direct sales offices and distributors in approximately 50 countries. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Wright Medical Group N.V.’s ISS Governance QualityScore as of September 1, 2017 is 5. The pillar scores are Audit: 10; Board: 1; Shareholder Rights: 2; Compensation: 9.